EntheoTech operates multidisciplinary clinics offering medically driven psychedelic-assisted therapy for mental health conditions and chronic pain. Their core offering, Odyssey, combines ketamine administration with preparation and integration counseling. The company also conducts research to develop exclusive psilocybin strains and validate their therapeutic protocols.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals with chronic pain and mental health conditions find traditional treatments insufficient, leading to persistent suffering and reduced quality of life. The current healthcare landscape often lacks integrated approaches that address both the physical and psychological dimensions of these complex conditions.
Solution
EntheoTech provides an integrative healthcare model focused on treating chronic pain and mental health conditions through medically supervised psychedelic-assisted therapy. Their core offering, the Odyssey™ program, delivers personalized ketamine therapy sessions administered by a medical team, complemented by structured preparation and integration counseling. This holistic approach aims to facilitate lasting therapeutic outcomes by addressing the multifaceted nature of these conditions. The company also engages in research and development of novel psilocybin strains and treatment protocols to advance the field of psychedelic medicine.
Target Audience
The primary target audience includes individuals suffering from chronic pain and mental health conditions who have not found adequate relief from conventional treatments, as well as healthcare providers seeking advanced therapeutic modalities.
Features
- Odyssey™ program: Personalized ketamine-assisted therapy (KAT) for chronic pain and mental health.
- Integrated therapeutic support: Includes pre-therapy preparation and post-therapy integration counseling.
- Multidisciplinary approach: Combines pharmacological interventions with practices like breathwork and mindfulness.
- Proprietary psilocybin research: Development of exclusive psilocybin strains and data collection on treatment protocols.
- Medical supervision: Ketamine administration by a qualified medical team.
- Focus on chronic pain and mental health conditions: Addresses depression, anxiety, PTSD, and chronic pain syndromes.